We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00216281
Recruitment Status : Terminated
First Posted : September 22, 2005
Last Update Posted : March 26, 2013
Sponsor:
Collaborators:
Hoffmann-La Roche
Shekhar, Anantha M.D., Ph.D.
Information provided by (Responsible Party):
Indiana University ( Indiana University School of Medicine )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : October 2006
  Study Completion Date : September 2008